ALZHEIMEND Trademark

Trademark Overview


On Thursday, March 2, 2023, a trademark application was filed for ALZHEIMEND with the United States Patent and Trademark Office. The USPTO has given the ALZHEIMEND trademark a serial number of 97820532. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, December 12, 2023. This trademark is owned by PHARMZANDIA CORPORATION. The ALZHEIMEND trademark is filed in the Pharmaceutical Products category with the following description:

Liquid nutritional supplement
alzheimend

General Information


Serial Number97820532
Word MarkALZHEIMEND
Filing DateThursday, March 2, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, December 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLiquid nutritional supplement
Translation of Words in MarkThe wording Alzheimend has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePHARMZANDIA CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWalnut, CA 91789

Trademark Events


Event DateEvent Description
Tuesday, December 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 12, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, December 12, 2023SUSPENSION LETTER WRITTEN
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023NEW APPLICATION ENTERED